HEMLIBRA 60MG/0.4ML INJECTION

Yes, HEMLIBRA 60MG/0.4ML INJECTION can be self-administered at home after proper training and instructions from a healthcare professional. However, the decision to self-administer should be made in consultation with the healthcare team.

Yes, HEMLIBRA 60MG/0.4ML INJECTION is approved for use in pediatric patients with hemophilia A. The dosage and administration may vary depending on the age and weight of the child, and it should be prescribed and monitored by a healthcare professional.

HEMLIBRA 60MG/0.4ML INJECTION is specifically designed for the treatment of hemophilia A, which is caused by a deficiency of clotting factor VIII. It is not intended for other types of hemophilia, such as hemophilia B.

HEMLIBRA 60MG/0.4ML INJECTION is administered as a subcutaneous injection, generally, it is given once a week, every two weeks, or every four weeks, depending on the treatment plan determined by the healthcare provider. The frequency of the administration depends on your disease condition and other factors.

Before you start using HEMLIBRA 60MG/0.4ML INJECTION, talk to your doctor and carefully follow their instructions on when to use a bypassing agent and the dose and schedule you should use. It increases the ability of your blood to clot. Therefore, the dose of bypassing agent required may be lower than the dose you used before starting Hemlibra.

It is important to inform your doctor about all the medicines, supplements, and herbal products you are currently taking to avoid potential interactions with HEMLIBRA 60MG/0.4ML INJECTION.

This medicine is given as a shot under your skin. It is usually injected into the upper outer arms, thighs, or stomach. Use a different body area each time you give yourself a shot. Keep track of where you give each shot to make sure you rotate body areas. Do not inject into skin areas that are tender, red, bruised, hard, or not intact, or into areas with moles or scars. Use a new needle and syringe each time you inject your medicine.

Women should use an effective form of birth control to keep from getting pregnant. Tell your doctor right away if you think you have become pregnant. Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.

The active molecule/combination used in HEMLIBRA 60MG/0.4ML INJECTION is EMICIZUMAB.

HEMLIBRA 60MG/0.4ML INJECTION is prescribed for the treatment of Blood Disorders, specifically Hemophilia A.

Hemophilia A is a type of blood disorder caused by a deficiency of clotting factor VIII.